NCT04961203

Brief Summary

In view to develop a study design for a study that would analyze the pathways of palliative care prospectively, this work will identify the individual factors that would be significantly associated with typical pathways of palliative care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2021

Completed
14 days until next milestone

Study Start

First participant enrolled

June 15, 2021

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 14, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

July 14, 2021

Status Verified

June 1, 2021

Enrollment Period

12 months

First QC Date

June 1, 2021

Last Update Submit

July 2, 2021

Conditions

Keywords

Palliative carePathways

Outcome Measures

Primary Outcomes (1)

  • Retrospective study describing the patient care pathway

    The files analyzed retrospectively concern the period from January 01, 2020 to December 31, 2020.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient met by the palliative care mobile team or admitted in palliative care unit and who died between January 2020 and December 2020.

You may qualify if:

  • Patient met by the palliative care mobile team or admitted in palliative care unit
  • Patient who died between January 2020 and December 2020.

You may not qualify if:

  • Minors and incapacitated adults, or deprived of liberty
  • Patient who explained their disagreement with the use of medical data for research purposes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de soins Palliatifs - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Laurent Calvel, MD, PhD

    Service de soins Palliatifs - Hôpitaux Universitaires de Strasbourg

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 1, 2021

First Posted

July 14, 2021

Study Start

June 15, 2021

Primary Completion

June 1, 2022

Study Completion

June 1, 2022

Last Updated

July 14, 2021

Record last verified: 2021-06

Locations